Titel

Merkliste
1 Ergebnisse

Changes in clinical, respiratory and laboratory parameters ..:

Piero Ruggenenti (180711) ; Fabiano Di Marco (3171375) ; Monica Cortinovis (5399138)...
https://figshare.com/articles/figure/Changes_in_clinical_respiratory_and_laboratory_parameters_in_eculizumab-treated_patients_and_all_controls_and_correlations_between_changes_in_respiratory_rate_and_ex_vivo_C5b-9_deposition_at_different_time_points_in_eculizumab-treated_patie/17300715. , 2021

Link: https://doi.org/10.1371/journal.pone.0261113.g003

RT Journal
T1 <Title>Changes in clinical, respiratory and laboratory parameters in eculizumab-treated patients and all controls, and correlations between changes in respiratory rate and ex vivo C5b-9 deposition at different time points in eculizumab-treated patients and "biochemical" controls considered as a whole</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_17300715&Exemplar=1&LAN=DE
				
A1 Piero Ruggenenti (180711)
A1 Fabiano Di Marco (3171375)
A1 Monica Cortinovis (5399138)
A1 Luca Lorini (11858730)
A1 Silvia Sala (11858733)
A1 Luca Novelli (9987481)
A1 Federico Raimondi (9987487)
A1 Sara Gastoldi (9593645)
A1 Miriam Galbusera (9593651)
A1 Roberta Donadelli (5854070)
A1 Caterina Mele (232574)
A1 Rossella Piras (5854076)
A1 Marina Noris (2278702)
A1 Valentina Portalupi (5399153)
A1 Laura Cappelletti (11858736)
A1 Camillo Carrara (11858739)
A1 Federica Tomatis (11858742)
A1 Silvia Bernardi (652621)
A1 Annalisa Perna (6560222)
A1 Tobia Peracchi (11133337)
A1 Olimpia Diadei (180735)
A1 Ariela Benigni (114455)
A1 Giuseppe Remuzzi (180748)
YR 2021
K1 Biochemistry
K1 Medicine
K1 Cell Biology
K1 Molecular Biology
K1 Neuroscience
K1 Biotechnology
K1 Immunology
K1 Developmental Biology
K1 Marine Biology
K1 Cancer
K1 Mental Health
K1 Infectious Diseases
K1 main study limitations
K1 findings need confirmation
K1 ex vivo </
K1 coronavirus disease 2019
K1 ci ): 2
K1 10 &# 8211
K1 09 &# 8211
K1 08 &# 8211
K1 discharged without complications
K1 ci ): 0
K1 0 – 121
K1 0 ± 4
K1 3 ± 3
K1 secondary outcomes included
K1 respiratory rate correlated
K1 baseline serum creatinine
K1 84 )
K1 p
K1 72 )
K1 70 )
K1 treated patients died
K1 19 patients admitted
K1 8 ± 7
K1 respiratory rate
K1 &# 8804
K1 treated patients
K1 3 breaths
K1 chronic complications
K1 six patients
K1 xlink ">
K1 ventilator support
K1 tolerated well
K1 thrombi deposition
K1 tests normalised
K1 standard therapy
K1 significant even
JF https://figshare.com/articles/figure/Changes_in_clinical_respiratory_and_laboratory_parameters_in_eculizumab-treated_patients_and_all_controls_and_correlations_between_changes_in_respiratory_rate_and_ex_vivo_C5b-9_deposition_at_different_time_points_in_eculizumab-treated_patie/17300715
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0261113.g003
DO https://doi.org/10.1371/journal.pone.0261113.g003
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)